Diffuse Large B Cell Lymphoma (DLBCL) Trials in Italy, 2026
Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.
About this register
This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,871 studies in total at the last sync on 01 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.
This page shows the 10 of those studies listing the condition Diffuse Large B Cell Lymphoma (DLBCL).
How many Diffuse Large B Cell Lymphoma (DLBCL) trials are recruiting in Italy?
6 of the 10 studies on this page are recruiting new participants as of the 01 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.
Summary by phase
| Phase | Studies | Recruiting | Share |
|---|---|---|---|
| Observational | 6 | 3 | 60% |
| Phase 1 | 2 | 1 | 20% |
| Not applicable | 1 | 1 | 10% |
| Phase 3 | 1 | 1 | 10% |
Most active sponsors
| Lead sponsor | Studies | Recruiting |
|---|---|---|
| Fondazione Italiana Linfomi - ETS | 3 | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 | 1 |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 1 | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 | 1 |
| Istituto Oncologico Veneto IRCCS | 1 | 0 |
| Nurix Therapeutics, Inc. | 1 | 1 |
| Regeneron Pharmaceuticals | 1 | 1 |